Clinical course of COVID-19 in patients with pre-existing decompensated cirrhosis: initial report from China
ConclusionThe case series raise the possibility that decompensated cirrhosis may be a risk factor for a poor outcome in patients with COVID-19.
Source: Hepatology International - Category: Infectious Diseases Source Type: research
More News: Alcoholism | China Health | Cirrhosis | COVID-19 | Hepatitis | Hepatitis B | Hypertension | Infectious Diseases | Outbreaks | Respiratory Medicine